ASML gains as analyst optimism builds on stronger 2026 outlook

ASML Holding N.V. (ASML) is up 4.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is a fresh wave of analyst optimism after UBS reiterated its Buy rating and raised its price target, which appears to have reinforced bullish sentiment around ASML’s long-term demand outlook. The move also seems supported by the company’s recent guidance increase and continued investor confidence that AI-related chip spending will keep lifting orders for advanced lithography tools.

Details:

UBS recently kept a Buy rating on ASML and lifted its target price to EUR 2,350, giving investors a new positive catalyst.

In its July 15, 2026 second-quarter release, ASML reported net sales of €9.3 billion and raised its full-year 2026 sales outlook to €43 billion to €45 billion.

ASML also guided for third-quarter 2026 sales of €11.0 billion to €12.0 billion, signaling expectations for another step up in revenue.

The company highlighted ongoing demand tied to leading-edge chip manufacturing, including High-NA EUV adoption, which has kept the broader growth narrative intact.

Sources:

ASML, MarketScreener, SEC

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

EARLY ACCESS

Receive ASML Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$ASML Hedge Fund Activity

We have seen 1,348 institutional investors add shares of $ASML stock to their portfolio, and 971 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 2,395,859 shares (+inf%) to their portfolio in Q2 2026, for an estimated $4,766,417,728
FMR LLC added 2,329,935 shares (+74.0%) to their portfolio in Q2 2026, for an estimated $4,635,265,886
INVESCO LTD. added 2,015,103 shares (+179.1%) to their portfolio in Q2 2026, for an estimated $4,008,926,512
CAPITAL INTERNATIONAL INVESTORS added 671,772 shares (+38.0%) to their portfolio in Q2 2026, for an estimated $1,336,450,087
VAN ECK ASSOCIATES CORP added 592,125 shares (+31.7%) to their portfolio in Q2 2026, for an estimated $1,177,997,160
EDGEWOOD MANAGEMENT LLC removed 510,252 shares (-54.1%) from their portfolio in Q2 2026, for an estimated $1,015,115,738
BAROMETER CAPITAL MANAGEMENT INC. removed 505,290 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $646,412,444

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$ASML Congressional Stock Trading

Members of Congress have traded $ASML stock 6 times in the past 6 months. Of those trades, 6 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $ASML stock by members of Congress over the last 6 months:

REPRESENTATIVE JARED MOSKOWITZ has traded it 4 times. They made 4 purchases worth up to $60,000 on 03/31, 03/23 and 0 sales.
SENATOR ALAN ARMSTRONG has traded it 2 times. They made 2 purchases worth up to $115,000 on 03/31, 03/30 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$ASML Price Targets

Multiple analysts have issued price targets for $ASML recently. We have seen 5 analysts offer price targets for $ASML in the last 6 months, with a median target of $2200.0.

Here are some recent targets:

David Dai from Bernstein set a target price of $2623.0 on 07/06/2026
Didier Scemama from B of A Securities set a target price of $2345.0 on 06/22/2026
Joseph Quatrochi from Wells Fargo set a target price of $2200.0 on 06/22/2026
Sandeep Deshpande from JP Morgan set a target price of $2200.0 on 06/03/2026
Srini Pajjuri from RBC Capital set a target price of $1700.0 on 04/16/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.